Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes

Diagnosis and classification of diabetes mellitus, Diabetes Care, 31 Suppl. 1, 2008, S55–60.

Hollander, 2007, Gestational diabetes: a review of the current literature and guidelines, Obstet. Gynecol. Surv., 62, 125, 10.1097/01.ogx.0000253303.92229.59

Reaven, 1993, Role of insulin resistance in human disease (syndrome X): an expanded definition, Annu. Rev. Med., 44, 121, 10.1146/annurev.me.44.020193.001005

Haffner, 1990, Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?, JAMA, 263, 2893, 10.1001/jama.263.21.2893

Haffner, 1998, Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction, N. Engl. J. Med., 339, 229, 10.1056/NEJM199807233390404

Yki-Jarvinen, 2003, Insulin resistance and endothelial dysfunction, Best Pract. Res. Clin. Endocrinol. Metab., 17, 411, 10.1016/S1521-690X(03)00033-2

Libby, 2004, Inflammation and atherosclerosis: role of C-reactive protein in risk assessment, Am. J. Med., 116, 9S, 10.1016/j.amjmed.2004.02.006

Grant, 2007, Diabetes mellitus as a prothrombotic condition, J. Intern. Med., 262, 157, 10.1111/j.1365-2796.2007.01824.x

Juhan-Vague, 1997, PAI-1, obesity, insulin resistance and risk of cardiovascular events, Thromb. Haemost., 78, 656, 10.1055/s-0038-1657607

Lane, 2006, Noninvasive assessment of preclinical atherosclerosis, Vasc. Health Risk Manag., 2, 19, 10.2147/vhrm.2006.2.1.19

Simonet, 1997, Osteoprotegerin: a novel secreted protein involved in the regulation of bone density, Cell, 89, 309, 10.1016/S0092-8674(00)80209-3

Min, 2000, Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis, J. Exp. Med., 192, 463, 10.1084/jem.192.4.463

Kong, 1999, OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis, Nature, 397, 315, 10.1038/16852

Kong, 2000, Osteoprotegerin ligand: a regulator of immune responses and bone physiology, Immunol. Today, 21, 495, 10.1016/S0167-5699(00)01718-7

Anderson, 1997, A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function, Nature, 390, 175, 10.1038/36593

Emery, 1998, Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL, J. Biol. Chem., 273, 14363, 10.1074/jbc.273.23.14363

Dhore, 2001, Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques, Arterioscler. Thromb. Vasc. Biol., 21, 1998, 10.1161/hq1201.100229

Browner, 2001, Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women, J. Clin. Endocrinol. Metab., 86, 631, 10.1210/jc.86.2.631

Abedin, 2007, Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study), Am. J. Cardiol., 99, 513, 10.1016/j.amjcard.2006.08.064

Kiechl, 2004, Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease, Circulation, 109, 2175, 10.1161/01.CIR.0000127957.43874.BB

Avignon, 2005, Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients, Diabetes Care, 28, 2176, 10.2337/diacare.28.9.2176

Shin, 2006, Elevated serum osteoprotegerin levels are associated with vascular endothelial dysfunction in type 2 diabetes, Diabetes Care, 29, 1664, 10.2337/dc06-0631

Xiang, 2006, The relationship between plasma osteoprotegerin and endothelium-dependent arterial dilation in type 2 diabetes, Diabetes, 55, 2126, 10.2337/db06-0231

Howard, 1993, Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC investigators, Stroke, 24, 1297, 10.1161/01.STR.24.9.1297

Lim, 2008, Normal value of carotid intima-media thickness—a surrogate marker of atherosclerosis: quantitative assessment by B-mode carotid ultrasound, J. Am. Soc. Echocardiogr., 21, 112, 10.1016/j.echo.2007.05.002

Clauss, 1957, Rapid physiological coagulation method in determination of fibrinogen, Acta Haematol., 17, 237, 10.1159/000205234

Malyankar, 2000, Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells, J. Biol. Chem., 275, 20959, 10.1074/jbc.C000290200

Knudsen, 2003, Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications, Eur. J. Endocrinol., 149, 39, 10.1530/eje.0.1490039

Nellemann, 2007, Simvastatin reduces plasma osteoprotegerin in type 2 diabetic patients with microalbuminuria, Diabetes Care, 30, 3122, 10.2337/dc07-0919

Mack, 2000, Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography, Atherosclerosis, 150, 371, 10.1016/S0021-9150(99)00383-4

Bots, 1997, Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study, Circulation, 96, 1432, 10.1161/01.CIR.96.5.1432

Brohall, 2006, Carotid artery intima-media thickness in patients with Type 2 diabetes mellitus and impaired glucose tolerance: a systematic review, Diabet. Med., 23, 609, 10.1111/j.1464-5491.2005.01725.x

Bo, 2007, Should we consider gestational diabetes a vascular risk factor?, Atherosclerosis, 194, e72, 10.1016/j.atherosclerosis.2006.09.017

Tarim, 2006, Early onset of subclinical atherosclerosis in women with gestational diabetes mellitus, Ultrasound Obstet. Gynecol., 27, 177, 10.1002/uog.2687

Xiang, 2005, Effect of thiazolidinedione treatment on progression of subclinical atherosclerosis in premenopausal women at high risk for type 2 diabetes, J. Clin. Endocrinol. Metab., 90, 1986, 10.1210/jc.2004-1685

Xiang, 2007, Effect of pioglitazone on progression of subclinical atherosclerosis in non-diabetic premenopausal Hispanic women with prior gestational diabetes, Atherosclerosis

Erdogan, 2004, Intima-media thickness of the carotid arteries is related to serum osteoprotegerin levels in healthy postmenopausal women, Neurol. Res., 26, 658, 10.1179/016164104225014157

Schlieper, 2007, Is there a correlation between C-reactive protein and calcification inhibitors with cardiovascular parameters and risk factors in hemodialysis patients?, Dtsch Med Wochenschr, 132, 1820, 10.1055/s-2007-984969

Brandstrom, 2002, A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function, Biochem. Biophys. Res. Commun., 293, 13, 10.1016/S0006-291X(02)00137-7

Brandstrom, 2004, A single nucleotide polymorphism in the promoter region of the osteoprotegerin gene is related to intima-media thickness of the carotid artery in hypertensive patients. The Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA), Blood Press, 13, 152, 10.1080/08037050410035563

Price, 2001, Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D, Arterioscler. Thromb. Vasc. Biol., 21, 1610, 10.1161/hq1001.097102

Bucay, 1998, osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification, Genes Dev., 12, 1260, 10.1101/gad.12.9.1260

Proudfoot, 2001, Biology of calcification in vascular cells: intima versus media, Herz, 26, 245, 10.1007/PL00002027

Farhan, 2006, Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes, Eur. J. Clin. Invest., 36, 345, 10.1111/j.1365-2362.2006.01630.x

Morimitsu, 2007, Fibrinolytic dysfunction after gestation is associated to components of insulin resistance and early type 2 diabetes in latino women with previous gestational diabetes, Diabetes Res. Clin. Pract., 78, 340, 10.1016/j.diabres.2007.04.013

Heitritter, 2005, Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus, J. Clin. Endocrinol. Metab., 90, 3983, 10.1210/jc.2004-2494

Ostergard, 2006, Endothelial function and biochemical vascular markers in first-degree relatives of type 2 diabetic patients: the effect of exercise training, Metabolism, 55, 1508, 10.1016/j.metabol.2006.06.024

Vik, 2006, Serum osteoprotegerin in young survivors of myocardial infarction, Thromb. Haemost., 95, 881, 10.1160/TH05-10-0662

Coustan, 1993, Gestational diabetes: predictors of subsequent disordered glucose metabolism, Am. J. Obstet. Gynecol., 168, 1139, 10.1016/0002-9378(93)90358-P

Yun, 2007, Modifiable risk factors for developing diabetes among women with previous gestational diabetes, Prev. Chronic Dis., 4, A07